Korea Investment CORP lessened its holdings in shares of Stryker Corporation (NYSE:SYK) by 1.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 121,728 shares of the medical technology company’s stock after selling 1,265 shares during the quarter. Korea Investment CORP’s holdings in Stryker Corporation were worth $16,893,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of SYK. Bollard Group LLC raised its position in shares of Stryker Corporation by 0.4% in the 2nd quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after buying an additional 3 shares during the period. Baystate Wealth Management LLC raised its position in shares of Stryker Corporation by 2.1% in the 1st quarter. Baystate Wealth Management LLC now owns 1,066 shares of the medical technology company’s stock worth $139,000 after buying an additional 22 shares during the period. James Investment Research Inc. purchased a new position in shares of Stryker Corporation in the 2nd quarter worth $155,000. Guardian Life Insurance Co. of America raised its position in shares of Stryker Corporation by 0.8% in the 1st quarter. Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company’s stock worth $158,000 after buying an additional 9 shares during the period. Finally, Assetmark Inc. raised its position in shares of Stryker Corporation by 0.3% in the 1st quarter. Assetmark Inc. now owns 1,274 shares of the medical technology company’s stock worth $168,000 after buying an additional 4 shares during the period. 74.16% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION WARNING: This piece was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally copied and republished in violation of United States & international copyright and trademark law. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/09/04/stryker-corporation-syk-holdings-decreased-by-korea-investment-corp.html.

In other Stryker Corporation news, insider Graham A. Mclean sold 1,124 shares of the business’s stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $146.26, for a total transaction of $164,396.24. Following the completion of the transaction, the insider now owns 8,983 shares of the company’s stock, valued at approximately $1,313,853.58. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider David Floyd sold 19,305 shares of the business’s stock in a transaction on Wednesday, July 12th. The stock was sold at an average price of $144.56, for a total transaction of $2,790,730.80. The disclosure for this sale can be found here. In the last ninety days, insiders sold 25,429 shares of company stock valued at $3,686,927. 7.40% of the stock is owned by company insiders.

Several research analysts recently weighed in on the company. Canaccord Genuity reaffirmed a “buy” rating and issued a $155.00 target price (down from $158.00) on shares of Stryker Corporation in a research report on Thursday, August 24th. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $155.00 target price on shares of Stryker Corporation in a research report on Friday. BidaskClub raised Stryker Corporation from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. Zacks Investment Research lowered Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Wednesday, August 23rd. Finally, Argus reaffirmed a “buy” rating and issued a $160.00 target price on shares of Stryker Corporation in a research report on Tuesday, August 29th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the stock. Stryker Corporation presently has an average rating of “Hold” and an average price target of $145.73.

Shares of Stryker Corporation (NYSE SYK) opened at 141.09 on Monday. The stock’s 50 day moving average price is $144.55 and its 200 day moving average price is $137.64. Stryker Corporation has a 52 week low of $106.48 and a 52 week high of $148.84. The firm has a market capitalization of $52.78 billion, a P/E ratio of 31.49 and a beta of 0.82.

Stryker Corporation (NYSE:SYK) last released its quarterly earnings data on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.51 by $0.02. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The business had revenue of $3.01 billion during the quarter, compared to analyst estimates of $2.98 billion. During the same quarter in the previous year, the business earned $1.39 EPS. Stryker Corporation’s quarterly revenue was up 6.1% compared to the same quarter last year. On average, analysts predict that Stryker Corporation will post $6.47 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be paid a $0.425 dividend. This represents a $1.70 annualized dividend and a dividend yield of 1.20%. The ex-dividend date is Thursday, September 28th. Stryker Corporation’s payout ratio is presently 37.95%.

Stryker Corporation Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.